News Regulatory AffairsHealth Canada approves Empaveli (pegcetacoplan) for C3G/IC-MPGN Health Canada has approved Empaveli (pegcetacoplan) as the first treatment… 0 10 0 April 16, 2026
Drug ApprovalsHealth Canada approves Cysklar (cysteamine ophthalmic solution) for cystinosis-related corneal crystals Takeaways: Cysklar gives Canada’s small cystinosis community a dedicated, easy‑to‑use… 0 1 0 April 15, 2026
Drug ApprovalsHealth Canada grants NOC to Saphnelo (anifrolumab) SC autoinjector for SLE Takeaways: AstraZeneca deepens its Saphnelo franchise in Canada by adding… 0 1 0 April 13, 2026
Drug ApprovalsHealth Canada approves Denoza, a biosimilar to Prolia (denosumab) Takeaways: Apotex’s Denoza biosimilar gives Canada a home‑grown denosumab option,… 0 1 0 April 7, 2026
Clinical PipelineHealth Canada clears CTA for AFTX-201 in BAG3 DCM, to be evaluated in Phase 1/2 UPBEAT trial Takeaways: Health Canada’s CTA clearance positions Affinia among the first… 0 1 0 April 6, 2026